GlycoMimetics Reports Delay in Initiation of Phase 3 Trial with Rivipansel
September 26, 2014 at 09:03 AM EDT
GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it has been informed by Pfizer (NYSE: PFE), the company responsible for ...
